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Background and purpose: There is little evidence available on the use of robot-assisted therapy in subacute stroke
patients. A randomized controlled trial was carried out to evaluate the short-time efficacy of intensive robot-assisted
therapy compared to usual physical therapy performed in the early phase after stroke onset.
Methods: Fifty-three subacute stroke patients at their first-ever stroke were enrolled 30 ± 7 days after the acute event
and randomized into two groups, both exposed to standard therapy. Additional 30 sessions of robot-assisted therapy
were provided to the Experimental Group. Additional 30 sessions of usual therapy were provided to the Control Group.
The following impairment evaluations were performed at the beginning (T0), after 15 sessions (T1), and at the end of
the treatment (T2): Fugl-Meyer Assessment Scale (FM), Modified Ashworth Scale-Shoulder (MAS-S), Modified Ashworth
Scale-Elbow (MAS-E), Total Passive Range of Motion-Shoulder/Elbow (pROM), and Motricity Index (MI).
Results: Evidence of significant improvements in MAS-S (p = 0.004), MAS-E (p = 0.018) and pROM (p < 0.0001) was found
in the Experimental Group. Significant improvement was demonstrated in both Experimental and Control Group in FM
(EG: p < 0.0001, CG: p < 0.0001) and MI (EG: p < 0.0001, CG: p < 0.0001), with an higher improvement in the Experimental
Group.
Conclusions: Robot-assisted upper limb rehabilitation treatment can contribute to increasing motor recovery in
subacute stroke patients. Focusing on the early phase of stroke recovery has a high potential impact in clinical
practice.
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A progressive decrease in stroke mortality has been
observed over the past years in western Countries to-
gether with a subsequent increase in survivors with re-
sidual impairments and disabilities that require assistance
[1]. The most frequent impairment caused by stroke is the
restriction of motor activity, which reduces muscle move-
ment and mobility [2], although stroke may also lead to
sensory and cognitive impairment as well. Moreover the
ability to carry out the activities of daily living (ADLs) in
an autonomous way and to be engaged in social and com-
munity participation is strongly reduced [3]. Up to 85% of
stroke patients experience hemiparesis immediately after
stroke, while a number of survivors between 55% and 75%* Correspondence: patrizio.sale@gmail.com
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unless otherwise stated.continue to experience motor deficits, together with a di-
minished quality of life [4].
The recovery of upper and lower limb function after
stroke injuries is a complex process and requires multidis-
ciplinary and multi-factorial approaches However, upper
limb functional recovery requires long physical rehabilita-
tion treatment in order to recover maximum independ-
ence and the highest quality of life possible. Different
intensive methods can be used to achieve these results
but no clear evidence for the best treatment is yet avail-
able [5]. Intensive task-oriented training could contrib-
ute to achieving upper and lower limb impairment
reduction even if this process is driven mainly by adap-
tive strategies that provide a compensation of impaired
motor activity [6-8].
Scientific evidence shows that a multi-factorial ap-
proach and high intensity therapy are able to improve
motor recovery of upper limbs in stroke rehabilitation. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[16-18] seem to increase motor recovery, due to effects on
somatosensory input, motor planning, soft tissue proper-
ties and spasticity.
A number of robotic devices, which have proven to
improve arm motor performance, at least in chronic
stroke patients, have been developed over the past dec-
ade to deliver targeted sensorimotor training to patients
with neurological diseases such as stroke.
Different robot-assisted rehabilitation approaches
have been provided in chronic stroke patients in order
to improve arm function, including mono-lateral ver-
sus bilateral training and/or proximal versus distal ap-
proaches [19]. Kwakkel and colleagues conducted a
meta-analysis of RCTs and reported a significant im-
provement in upper limb motor impairment, whereas they
did not find any significant changes in ADLs using upper
limb robot-assisted treatment in chronic stroke patients
[20].
Lo and colleagues demonstrated that the robotic system
for shoulder/elbow rehabilitation on chronic post-stroke
patients did not significantly improve motor performance
after 12 weeks compared to usual care or intensive ther-
apy. Nevertheless, secondary analyses showed that the
robot-assisted therapy compared to usual care rather than
intensive therapy improved outcomes over 36 weeks [21].
On the contrary, definitive scientific evidence on the use
of robotic upper limb treatment has not been found to
date in subacute stroke patients [22-24]. Indeed, only 3
randomized controlled trials (RCTs) with different meth-
odological approaches have been carried out [18]: the re-
sults showed that upper limb robotic training during the
subacute phase can contribute to improving functional
abilities more than chronic phase training without any
comparison with usual rehabilitative treatment. Moreover,
two RCTs were carried out to demonstrate the effective-
ness of distal upper limb robotic therapy in subacute
stroke patients without any significant result [25,26].
The objective of the two-center randomized controlled
observer-blind trial presented in this article is to evaluate
the effects of robot-assisted therapy on upper limb body
function (impairment) compared to usual intensive phys-
ical therapy, at the early phase after stroke onset. An ana-
lysis of clinical outcome measures at the middle and at the
end of the treatment is also provided.Methods
Participants
Eligible hemiparetic stroke survivors from San Raffaele
Pisana, Rome, Italy and Auxilium Vitae Rehabilitation
Centre, Volterra, Italy were recruited. The study in-
cluded only subacute stroke patients at their first-ever
stroke enrolled 30 ± 7 days after the acute event withischemic lesions and hemorrhagic forms only. The diag-
noses were confirmed with CT scan and/or MRI exam.
Inclusion criteria for both groups were: (a) first acute
event of cerebrovascular stroke; (b) unilateral paresis; (c)
ability to understand and follow simple instructions; (d)
ability to remain in a sitting posture. The following ex-
clusion criteria were identified: (e) bilateral impairment;
(f) severe sensory deficits in the paretic upper limb; (g)
cognitive impairment or behavioral dysfunction that would
influence the ability to comprehend or perform the experi-
ment; (h) refusal or inability to provide informed consent;
(i) other current severe medical problems.
The local Ethical Committee of both centers approved
the study. All patients gave informed consent to the
investigation.
Apparatus
The MIT-MANUS/InMotion2 (Interactive Motion Tech-
nologies, Inc., Watertown, MA, USA) (IM2) is a robotic
device designed for the rehabilitation of shoulder and
elbow segments [27] (Figure 1). The IM2 has two transla-
tional degrees of freedom (DoFs): shoulder abduction-
adduction and elbow flexion-extension. The robotic sys-
tem supports the execution of reaching movements in the
horizontal plane through an assist-as-needed control strat-
egy. In particular, an impedance-based control strategy is
implemented: the robot assists the motion of the upper
limb during the execution of planar trajectories according
to a mass-spring-damper model which mimics the inter-
action with the therapist through control parameters.
Based on the specific performance of each patient, these
parameters are adjusted during the therapy using data re-
corded by the robot sensors (force sensors, encoders, ta-
chometers). Physical quantities, such as position, velocity
and applied forces, were recorded at the robot end-
effector.
The device is designed to have a low intrinsic end-
point impedance (i.e., to be backdriveable, execute move-
ments without constraint and offer minimal resistance). A
visual feedback based on the patient’s motor performance
is provided every 80 movements. The paretic arm is placed
in a custom-made arm support (available for both arms)
fixed to the robot end-effector.
Procedures
Fifty-three inpatients with first-ever ischemic mono-
hemispheric stroke were randomly assigned to two
groups, Experimental Group (EG) and Control Group
(CG). The random allocation to treatment was concealed
and based upon dedicated software. A Lehemer algo-
rithm was applied to achieve a balanced allocation in the
EG and CG groups. Therapists were randomly assigned
to patients within each group using the same algorithm.
The clinical assessments were carried out by blinded
Figure 1 Experimental setup.
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and at the end of the treatment, after 30 sessions (T2).
All subjects underwent inpatient rehabilitation, con-
sisting of a daily 3-hour physiotherapy session, including
both dexterity and gait training, according to individu-
ally tailored exercise scheduling. In addition to usualFigure 2 Clock-like rehabilitation scenario.rehabilitation, eligible patients also received one daily ses-
sion of either experimental or control treatment according
to the random allocation procedure. Therapy was always
performed under the supervision of a physical therapist.
Each subject in the EG was asked to perform 30 ses-
sions (5 days a week for 6 weeks) of goal-directed, planar
Sale et al. Journal of NeuroEngineering and Rehabilitation 2014, 11:104 Page 4 of 8
http://www.jneuroengrehab.com/content/11/1/104reaching tasks, which emphasized shoulder and elbow
movements, moving from the center target to each of
the 8 peripheral targets, equally spaced on a 0.14 m ra-
dius circumference around a center target (Figure 2),
using the IM2 robot. In each session, patients were
asked to perform a series of 16 unassisted clockwise rep-
etitions to each target, followed by 3 series of 320
assisted clockwise repetitions. At the end of each adap-
tive series, the patient was asked to perform an add-
itional series of 16 unassisted clockwise movements.
After 45 minutes the session was stopped.
Each subject in CG received 30 sessions (5 days a week
for 6 weeks) of conventional rehabilitative treatment,
matching robot-assisted therapy of the same duration,
such as assisted stretching, shoulder and arm exercises,
and functional reaching tasks provided by experienced
physiotherapists [23]. Every missed session was caught
up and subjects who were not able to catch up sessions
or who interrupted the treatment for more than 3 con-
secutive days were excluded from the study.
Outcome measures
Clinical outcomes were assessed using valid and reliable
stroke tools that include all International Classification
of Functioning, Disability and Health levels.
The upper limb section of the Fugl-Meyer Test (FM)
[28], which is a global evaluation scale for impairment in
stroke patients, and the Modified Ashworth Scale-Shoulder
(MAS-S) and Elbow (MAS-E), as outcome measure asses-
sing spasticity [29], were selected as primary outcomes.
The secondary outcomes were Passive Range of Motion
(pROM), as the sum of shoulder and elbow movements
(shoulder flexion/extension, abduction, intra/extrarotation
and elbow extension), to assess the joints excursion
which could be considered correlated to spasticity [30],
and Motricity Index (MI) that globally assesses impair-
ment in stroke patients [31]. Trained professionals, who
were not involved in the research and were blind to group
allocation, performed all the assessments.
Sample calculation and statistical analysis
A pre-study power calculation estimated that 25 partici-
pants would provide 80% power with 5% alpha to detect
a difference of 9 ± 10 points in FM between the two
groups. To assess the homogeneity of the two groups by
age, length of illness and outcome measures, we used
Mann–Whitney U Test independent samples to com-
pare median scores, whilst the Fisher’s Exact Test was
used for frequencies.
With regard to interval variables, the 2 groups (EG
and CG) were compared at the intermediate phase
(difference T1 − T0) and at the end of the treatment
(difference T2 – T1) using a 2 × 2 repeated-measures ana-
lysis of variance (two-way ANOVA). In the presence ofstatistically significant effects, post-hoc comparisons were
performed by comparing the change between T0 and T1,
and between T0 and T2 using the Wilcoxon signed rank
test.
The alpha level for significance was set at p < 0.05.
Statistical analysis was carried out using the SPSS ver-
sion 19.0 (SPSS Inc, Chicago, Illinois, USA).
Results
130 patients were screened, 53 of whom satisfied the in-
clusion criteria and were randomly assigned to the groups
as follows: 26 to the EG and 27 to the CG. No dropouts
were observed during treatment within each group: all
subjects completed the study protocol (Figure 3). Despite
higher FM and MI values in the EG at T0 than in the CG,
the distribution of the study subjects (N = 53) by age, gen-
der, etiology, lesion side and outcome measures did not
show any significant difference between the two groups
(Table 1), as shown by the Mann–Whitney U test and
Fisher’s Exact Test which did not detect any statistical sig-
nificant differences at T0 between the two groups.
As shown in Table 2, the primary outcome analysis
using the two-way ANOVA test showed statistically sig-
nificant improvements in MAS-S (p = 0.004) and MAS-E
(p = 0.018) in the EG.
A not statistically significant decreasing trend of
MAS-S and increasing trend of MAS-E was found in the
CG.
FM improved significantly in both groups (EG: p <
0.0001, CG: p < 0.0001). It is noteworthy that the statis-
tical analysis of the change in FM between T0 and T1
and between T0 and T2 provided by a Wilcoxon signed
rank test showed a greater improvement in the EG than
the CG after the first 15 sessions (p < 0.0001 and p < 0.001,
respectively).
The secondary outcome showed statistically significant
improvements in pROM (p < 0.0001) and MI (p < 0.0001)
in the EG (Table 2), whereas the CG showed statistically
significant improvements in MI (p < 0.0001) and a not sta-
tistically significant increase in pROM. The statistical ana-
lysis of the change in pROM between T0 and T1 and
between T0 and T2 showed an increase just after the first
15 sessions (p < 0.0001) in the EG whilst pROM did not
change in the CG.
As regards MI, a greater improvement in the EG than
the CG after the first 15 sessions (p < 0.0001 and p = 0.008,
respectively) was observed.
Discussion
This study presents the results of a RCT carried out with
the aim of systematically evaluating the effects of robot-
assisted proximal upper limb treatment in subacute
stroke patients. The focus on the early phase of stroke
recovery is a further innovative feature of this study and
Assessed for eligibility (n=130)
Excluded  (n=77)
Not meeting inclusion criteria (n=61)
Declined to participate (n=16)
Other reasons (n=0)
Analysed EG (n=26)
Excluded from analysis (n=0 )
Allocated to intervention EG (n=26)
Received allocated intervention (n=26)
Did not receive allocated intervention (n=0)
Analysed CG (n=27)
Excluded from analysis (n=0)
Allocated to intervention CG (n=27)
Received allocated intervention (n=27)





Figure 3 Study CONSORT flow diagram (Abbreviation: EG, Experimental Group, CG, Control Group).








Subject 26 (49%) 27 (51%)
Dropouts 0 (0%) 0 (0%)
Compliants 26 (100%) 27 (100%)
Gender 1.000a
Female 11 (42%) 11 (41%)
Male 15 (58%) 16 (59%)
Etiology .100a
Hemorrhagic 1 (4%) 6 (22%)
Ischemic 25 (96%) 21 (78%)
Lesion Side .412a
Right 10 (38%) 14 (52%)
Left 16 (62%) 13 (48%)
Mean (SD) - Median
[25th-75th percentiles]
Age, years 67.7 (14.2) - 72.0
[65.8-77.0]
67.7 (14.2) - 73.0
[69.0-78.0]
.294b
CMSA 3.0 (1.2) - 2.0
[2.0-4.0]





Abbreviations: SD standard deviation, CMSA Chedoke-McMaster Stroke Assessment.
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of potential applicability to the population of stroke pa-
tients and fostering to treat patients with moderate to
severe upper limb impairment.
Previous studies on chronic stroke patients showed a
significant decrease in shoulder and elbow motor im-
pairment after the robot-assisted treatment [32,33] and
different systematic reviews have explored the effects of
intensive therapy on functional recovery [34,35], even if
a consensus on this issue has not yet been reached, in
particular as regards the effects on ADLs. Our previous
experience on chronic stroke patients demonstrated that
intensive robotic training can improve upper limb func-
tional activity in terms of ROM and FM [36-38].
Our results show that intensive robot-assisted treat-
ment in subacute stroke patients may significantly re-
duce motor impairment in the paretic upper limb, with
a statistically significant change in both pROM and
MAS after 15 sessions of robotic treatment.
At the end of the treatment (i.e., 30 sessions), FM and
MI improved significantly in both groups, even if the
improvement in FM was higher in the EG than in the
CG after 15 sessions, confirming that intensive training
provided by robotic device contributes to obtain better
results than usual treatment at the early stage of re-
habilitation [39].
Rehabilitation strategies for stroke patients currently
are focused on high-intensity, repetitive finalized and
task specific training, even if a standardized protocol for
Table 2 Clinical outcome measures at T0, T1 and T2
Baseline After 15 sessions End of treatment ANOVA T1-T0 T2-T0
CG: n = 27; CG: n = 27; CG: n = 27;
EG: n = 26 EG: n = 26 EG: n = 26
T0 T1 T2 p-value p-value p-value
(Mean ± Sd) (Mean ± Sd) (Mean ± Sd)
Motricity index
CG 30.30 ± 33.38 35.78 ± 34.20 39.56 ± 35.10 <0.0001 0.008 0.002
EG 43.88 ± 24.77 53.77 ± 25.80 57.77 ± 24.22 <0.0001 <0.0001 <0.0001
Fugl-Meyer
CG 20.33 ± 16.01 22.30 ± 16.52 23.96 ± 17.51 <0.0001 0.001 0.001
EG 26.81 ± 11.43 34.15 ± 12.49 35.46 ± 12.24 <0.0001 <0.0001 <0.0001
pROM
CG 791.48 ± 75.3 805.22 ± 66.2 792.59 ± 83.0 NS NS NS
EG 755.0 ± 105.1 787.31 ± 98.1 809.04 ± 90.5 <0.0001 <0.0001 <0.0001
MAS-S
CG 1.19 ± 1.0 1.19 ± 1.14 1.15 ± 1.17 NS NS NS
EG 1.15 ± 1.16 0.81 ± 1.10 0.73 ± 1.08 0.004 NS 0.030
MAS-E
CG 0.85 ± 0.91 0.85 ± 0.91 0.93 ± 0.96 NS NS NS
EG 1.12 ± 1.07 0.92 ± 1.02 0.73 ± 0.96 0.018 0.020 0.010
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frequency, has not yet been shared.
Moreover it is widely accepted that rehabilitation
treatment should start as soon as possible after the acute
event, although there is not enough evidence supporting
this assumption [40,41] and it remains still unclear i) the
optimal overall duration of the intensive treatment stage
and ii) if the use of technological devices may shorten it.
Spasticity usually appears days to weeks after the acute
event and, although it may improve or disappear in some
individuals, often becomes a permanent impairment as
shown by electromyography studies which demonstrates
that the increase in muscle tone reaches its maximum
values between 1 and 3 months after stroke [42-44].
In our study statistical analysis on pROM and MAS
shows that spasticity significantly decreased in the EG
rather than in the CG, demonstrating positive effects of
the robot-assisted treatment delivered in the early phase
of rehabilitation in subacute stroke patients without any
adverse events thus suggesting that the use of upper
limb robotic treatment at the initial stage of stroke re-
habilitation should be provided.
A limitation of this study relies on the use of outcome
measures focused on the changes in the impairment
level only and not on the changes in ADLs representing
the final objective of the rehabilitation process.
However as the aim of the study was to assess (i) the
effects on upper limb motor recovery and (ii) tocompare the effectiveness of robotic therapy and usual
care, clinical outcome measures exploring only body
functions as referred in the International Classification
of Functioning, Disability and Health (ICF) were used
[45].
Conclusions
Our results show that after 15 sessions of intensive robot-
assisted rehabilitation therapy, moderate-to-severe upper-
limb impaired stroke survivors improved more than those
who received intensive traditional therapy. This finding
was also confirmed after 30 sessions, although FM and MI
significantly improved in both groups at the end of the
treatment, showing an advantage in robot-assisted therapy
only in the early stage of rehabilitation training.
Despite robotic rehabilitation is more frequently deliv-
ered to chronic stroke patients, where effectiveness is more
associated with the intensity rather than with the specificity
of the robotic approach, our results show that robot-
assisted treatment provided in the subacute phase is able
to effectively improve motor performance of the upper
limb in a shorter time compared to usual intensive physio-
therapy, thus accelerating the trend of motor recovery.
Moreover, our results show that an intensive active
upper limb movement training in the rehabilitation of
subacute stroke patients is able to reduce spasticity con-
futing the hypothesis that it could be responsible for an
increased risk of spasticity development.
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